Ex parte WANG - Page 7




          Appeal No. 93-3228                                                          
          Application 07/796,023                                                      


          rejection pursuant to 37 CFR § 1.196(b) of claims 7-14, 21-25               
          and 28-31 under 35 U.S.C. § 112, second paragraph.                          

               B.  Statement Under 37 CFR § 1.196(c)                                  
               All of the prior art applied by the examiner in rejecting              
          the claims on appeal contains components other than a                       
          bioactive macromolecule and a lipid powder (see the analysis                
          of the references on pages 3-6 of the answer).  Because the                 
          subject matter defined by the claims is not clear, it is not                
          possible to assess whether this subject matter would have been              
          anticipated under § 102 or unpatentable under § 103.  See In                
          re Steele, 305 F.2d 859, 862-63, 134 USPQ 292, 295-96 (CCPA                 
          1962).  Accordingly, we have vacated all four prior art                     
          rejections.                                                                 
               The claims on appeal, if amended to read “consisting of”               
          instead of the presently claimed phrase “consisting                         
          essentially of”, would avoid the foregoing new ground of                    
          rejection under 35 U.S.C. § 112, second paragraph.  The term                
          “consisting of” has the accepted meaning of closing the claim               
          to the inclusion of materials other than those recited except               



                                          7                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007